Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin-Reference-Cited by-同舟云学术

Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin

Published:2022 Issue:24 Volume:14 Page:8709-8726
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Cheraga Nihad¹^ORCID,Ye Zheng¹,Xu Ming-Jie²,Zou Lin¹,Sun Ning-Cong¹,Hang Yue¹,Shan Cong-Jia²,Yang Zhong-Zhou²,Chen Li-Juan³,Huang Ning-Ping¹^ORCID

Affiliation:

1. State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, P. R. China

2. Nanjing University Medical School, Nanjing, 210093, China

3. Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China

Abstract

A smart nanoplatform based on hyaluronic acid was developed for targeted atherosclerosis combination therapy, which effectively attenuated the progression of the plaque by simultaneously reducing inflammation and oxidative stress at the aortic lesion.

Funder

Jiangsu Commission of Health

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NR/D1NR06514A

Reference77 articles.

1. Heart Disease and Stroke Statistics—2021 Update

2. Monocytes in atherosclerosis: subsets and functions